Disc Medicine (IRON) Other Non Operating Income (2021 - 2026)
Disc Medicine (IRON) reported Other Non Operating Income of $22000.0 for Q1 2026, up 833.33% year-over-year from $2357.1 in Q1 2025, and up 1200.0% quarter-over-quarter from -$2000.0 in Q4 2025.
Disc Medicine (IRON) Other Non Operating Income (2021 - 2026) Analysis & Trends
Disc Medicine (IRON) has 6 years of Other Non Operating Income data on file, last reported at $22000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $22000.0, up 833.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $70000.0 (up 1850.0% YoY), and the FY2025 annual result was $45000.0, up 2350.0% from the prior year.
- Other Non Operating Income improved to $22000.0 in Q1 2026 per IRON's latest filing, from -$2000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $3.4 million in Q4 2022 and troughed at -$18000.0 in Q3 2025.
- A 5-year average of $253714.3 and a median of $1000.0 in 2024 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2025 and 2026: Other Non Operating Income plunged 300.0% in 2025, then soared 833.33% in 2026.
- A 5-year view of Other Non Operating Income shows it stood at $3.4 million in 2022, then plunged by 100.3% to -$10000.0 in 2023, then soared by 130.0% to $3000.0 in 2024, then tumbled by 166.67% to -$2000.0 in 2025, then surged by 1200.0% to $22000.0 in 2026.
- Business Quant data shows IRON's Other Non Operating Income at $22000.0 in Q1 2026, -$2000.0 in Q4 2025, and -$18000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Disc Medicine | 2.54 Bn | 1.81 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Sep 30, 2025 | -18,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | -13,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -10,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2023 | -5,000.00 |
| Dec 31, 2022 | 3.39 Mn |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | -5.05 Mn |